Astra Systems' mission is to provide innovative, cutting-edge fusion technology that enhances access to critical medical isotopes, accelerates fusion research, and lays the groundwork for sustainable energy systems.
Led by Talmon Firestone, CEO, and Dr. Tom Wallace-Smith, CTO; Astral Systems is currently focused on solving the growing crisis surrounding the international medical isotope shortage, which is severely impacting cancer diagnosis and treatments.
Astral’s compact reactors' unparalleled performance means they are poised to produce enough neutrons to offer an evergreen supply of isotopes, curtailing global manufacturing shortages.